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Abstract: HIV self-testing has emerged as a safe and effective approach to increase the access to
and uptake of HIV testing and treatment, especially for key populations. Applying self-testing to
hepatitis C virus (HCV) may also offer an additional way to address low coverage of HCV testing
and to accelerate elimination efforts. To understand the potential for HCV self-testing (HCVST),
an observational study was conducted to assess the acceptability and usability of the OraQuick®
HCV Self-Test (prototype) among people who inject drugs (PWID) and men who have sex with men
(MSM) in Thai Nguyen, a province in northern Vietnam. A total of 105 PWID and 104 MSM were
eligible and agreed to participate in the study. Acceptability, defined as the proportion of participants
among eligible subjects who agreed to participate in the study, was 92.9% in PWID and 98.6% in
MSM. Compared to MSM, PWID were older (median age: 45 vs. 22 years; p < 0.0001) and had a
lower education level (high school and college: 38.1% vs. 100%; p < 0.0001). HCVST usability was
high among MSM with fewer observed mistakes, difficulties, or participants requiring assistance
(33.7%, 28.8%, and 17.3%, respectively) compared to PWID (62.9%, 53.3%, and 66.7%, respectively; all
p < 0.0001)). Inter-reader and inter-operator agreement were good in both groups (Kappa coefficient
range: 0.61–0.99). However, the concordance between HCVST and study staff -read or performed
HCV testing was lower among PWID than MSM (inter-reader concordance 88.6% vs. 99.0% and
inter-operator concordance 81.9% vs. 99%). Overall, HCVST was highly acceptable with moderate to
high usability among PWID and MSM in Thai Nguyen. Efforts to provide support and assistance
may be needed to optimize performance, particularly for PWID populations and for those who are
older and with lower literacy or education levels.
Keywords: HCV; self-testing; oral fluid; PWID; MSM; Vietnam
1. Introduction
Viral hepatitis B and C are major causes of morbidity and mortality worldwide. To-
gether, they lead to approximately 1.34 million deaths per year [1]. In 2015, an estimated
71 million people had chronic hepatitis C virus (HCV) infection worldwide, and around
three-quarters of them lived in low- and middle-income countries [1]. Despite the avail-
ability of treatment and a cure for HCV, less than 20% of people with chronic hepatitis C
have been tested and are aware of their infection [1].
Most transmission of HCV in high-income settings, including North America and
Western and Eastern Europe, is due to previous or current injecting drug use. In all regions,
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injecting drug users are at higher risk of acquiring HCV than the general population, and
two-thirds of people who inject drugs (PWID) are estimated to have been infected with
HCV [2]. A high prevalence of HCV infection among men who have sex with men (MSM)
was recently reported in Taiwan with the HCV incidence per 1000 person years increased
from 12.9 in 2014 to 25.4 in 2018 [3]. In this study, syphilis infection was associated with
HCV seroconversion, which suggested that behaviors such as unprotected anal sex and
chemsex can increase the risk of sexually transmitted infections including HCV. Unsafe
injection and medical practices also contribute significantly to new infections in many low-
and middle-income countries with generalized epidemics. The most affected regions are
Eastern Mediterranean region and north and west Africa, where most infections are caused
by unsafe medical injections and other medical procedures.
Vietnam is among the 20 countries with the highest burden of chronic HCV infection
in the world and PWID are the most affected population. HCV antibody prevalence
among the general population in Vietnam ranged from 0.2–3.3% [4], but it is substantially
higher among PWID (74–87%) [5], HIV-infected individuals (22.9–89.0%) [6], HIV-infected
MSM (83.1–100%) and HIV-uninfected MSM (8.9–28.2%) [7], and multi-transfused and
dialysis patients (6–26.6%) [8,9]. A modelling exercise conducted by the Vietnam Ministry
of Health and World Health Organization (WHO) in 2017 estimated that there were nearly
one million people with chronic HCV infection in Vietnam. Although no disaggregated
data are available on HCV infection among high-prevalence key populations, the most
affected groups are PWID, MSM, and people who have had chronic hemodialysis and
multiple blood transfusions. The national response to viral hepatitis is based on a national
action plan on prevention and control of viral hepatitis (2015–2019) that presents a set
of comprehensive measures for prevention, alongside testing and treatment. Since 2019,
direct-acting antivirals (DAA) have been included in the health insurance reimbursement
list. However, the patient copayment rate is still as high as 50%, resulting in limited access
to HCV treatment. Advocacy for the reduction of patient copayment to 20% is ongoing.
The recent introduction of DAAs has transformed treatment options for persons with
chronic hepatitis C infection, leading to cure in more than 90% of treated individuals [10,11].
The WHO Global Health Sector Strategy on Viral Hepatitis 2016–2021 has a goal to eliminate
viral hepatitis C and B infection as a public health threat by 2030—defined as a reduction
in mortality by 65% and new infections by 90% [2]. The attainment of this goal will require
90% of those infected to be diagnosed, and 80% of those diagnosed to be treated. Therefore,
the substantial scale-up of testing and treatment of chronic HCV infection will be required
from the current level, where less than 20% of those infected are diagnosed.
WHO recommends treatment for all HCV-infected persons with pan-genotypic reg-
imens regardless of stage of the disease. WHO also recommends focused testing in the
most affected populations. These include those who have a history of exposure or high-risk
behaviors for HCV infection (e.g., PWID, people in prisons and other closed settings, MSM,
sex workers, HIV-infected persons, and children of mothers with chronic HCV infection
especially if co-infected with HIV), as well the general population in settings with an HCV
antibody prevalence ≥2–5% [12]. Although testing can be performed using simple and
affordable rapid diagnostic tests (RDT), access to HCV testing services and confirmatory
HCV viral load testing remains a major barrier to scale-up of treatment and elimination of
the disease. Many of those affected in high HCV burden countries live in rural or remote
settings or are members of high-risk marginalized populations such as PWID or MSM that
are hard to reach and stigmatized. Consequently, the uptake of HCV testing and treatment
in these high-risk populations remains low, and new strategic approaches to increase HCV
testing coverage are needed.
WHO recommends a range of HCV testing approaches, including a combination of
simple and affordable RDTs and confirmatory HCV viral load testing, particularly for those
most affected by chronic HCV infection [12]. Access to these services, however, is limited
in many settings due to stigma and discrimination, particularly for PWID and MSM, who
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also have high HCV prevalence and incidence. New strategic approaches to increase HCV
testing coverage especially in key populations such as PWIDs and MSM are needed.
One such approach is self-testing. In self-testing, an individual performs a simple
rapid test and interprets their own result, and it has been shown to significantly increase
the uptake of HIV testing services [13,14]. Numerous studies have shown self-testing to
be safe, accurate, effective and acceptable to many populations unreached by existing
services [13,15–17]. Since 2016, WHO has recommended self-testing for HIV and currently
lists four WHO prequalified products for self-testing [18,19]. As of July 2020, 88 countries
had national policies supporting self-testing and 41 were fully implementing—including
Vietnam where HIVST is widely implemented among key populations [20].
As for HIV, self-testing for HCV has potential to increase access to HCV testing for
those unreached by existing services and to contribute to efforts to treat, cure, and eliminate
HCV by 2030. To adapt and introduce self-testing for HCV, it is important to understand
the usability and acceptability among potential users. Thus, to inform the development
of HCV self-testing (HCVST) policy at global, regional, and national levels, we report on
findings from an observational study exploring HCVST acceptability and usability among
PWID and MSM in Vietnam.
2. Objective
The main study objectives were: (1) to determine the acceptability of and preferences
for HCVST among populations at high-risk for HCV infection (PWID and MSM) and (2)
to determine the usability (the ability to correctly perform test and interpret results) of an
HCV self-test.
3. Material and Methods
3.1. Study Design and Sample Size
This was an observational study. As there was no published data on acceptance and
usability of HCV self-testing, we made a conservative assumption that 50% of eligible
individuals will accept self-testing. To estimate the proportion in this study with a 95% con-
fidence interval based on Wilson’s score method, with ±10% margin of error, a minimum
sample size of 100 participants was required.
It was expected that the two groups would screen approximately 200 eligible subjects
during the recruitment period and approximately 100 participants would agree to perform
the test. In fact, we were able to reach higher number of eligible participants with higher
response rate. A total of 209 participants (105 PWID and 104 MSM) were included in the
study compared to the target of 100.
3.2. Setting and Participant Recruitment
The study was conducted in Thai Nguyen province, North Vietnam. Thai Nguyen is
one of the provinces with a high burden of HIV, and it also has strong networks of PWID
and MSM which have led community-based HIV testing since 2017 [20].
Peer educators recruited participants by reaching out to PWID and MSM communities
and using a short questionnaire to identify eligible individuals. The recruitment took place
at the offices of the three community-based organizations (two for PWID and one for MSM)
where community-based- and key population-led HIV testing is provided. In addition, an
online approach was also applied through social media (Facebook, Zalo, etc.).
Those eligible were invited to participate in the study, with separate sessions organized
for PWID and MSM, and offered an OraQuick HCV self-test kit (OraSure Technologies
Inc., Bethlehem, PA, USA). Those who agreed to participate provided a written informed
consent prior to study enrollment. Individuals with reactive results were referred to further
testing and treatment at a nearby facility according to the national guidance.
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3.3. Study Population—Eligibility Criteria
Individuals who self-identified as PWID and/or MSM were considered eligible and
enrolled in the study if they were ≥18 years old, were able to provide written informed
consent, had negative or unknown HCV status in the past 12 months, were able to read
Vietnamese, and had no previous experience self-testing for HIV and/or HCV. PWID en-
rolled also had to report use of un-prescribed intravenous drugs within the past 12 months.
MSM enrolled also had to report at least one anal sex episode with another man within the
past 12 months.
3.4. Study Procedures
Baseline information on demographic characteristics, exposure to risk factors, and
previous experience with HCV testing services was collected via questionnaires. The study
participants were provided with written and pictorial instructions in Vietnamese on how
to perform the HCVST and then were asked to perform the test and interpret the result.
The HCVST kit contained: one OraQuick® HCV Rapid Antibody Test (OraSure Technolo-
gies Inc., Bethlehem, PA, USA), developer solution, test stand (plastic), desiccant, and
manufacturer-provided instructions for use. While the OraQuick® HCV Rapid Antibody
Test is prequalified by WHO for professional use, all participants were informed that the
kit and instructions for self-testing were for research purposes only.
HCVST was performed at community-based organization offices—where community-
based testing for HIV is regularly conducted. In these key population-led testing sites,
5 principles of HIV testing including privacy were applied. Same principles were applied
for HCVST.
A study staff member silently observed the participants and documented any error
in testing procedure using a standardized checklist. The study staff did not provide any
assistance unless specifically requested by a participant or after multiple efforts to conduct
the test unassisted.
After self-testing was completed and the participants read their results, the test result
was re-read by a study staff member to measure inter-reader concordance. Then, a brief
post-testing interview was conducted to collect acceptability and preferences. Following
this, to measure inter-operator concordance, we compared the self-tester’s results to a
second OraQuick® HCV Rapid Antibody Test that was performed by a study staff member
who was blinded to the self-reported results.
Post-test counselling was provided by study staff from provincial Centre for Disease
Control. The key messages provided to individuals with reactive results were the meaning
of HCVST positive results, the necessity of retesting in health facility, the benefit of HCV
treatment, and the location of the health facility where participants could access HCV
testing, diagnosis, and treatment in Thai Nguyen province.
3.5. Data Analysis
The results are reported as percentage and median (range) as appropriate. The sta-
tistical significance of differences between groups was analyzed by the Fisher’s exact test
and Chi square test, and p values less than 0.05 were considered statistically significant.
Usability was assessed by calculating the frequencies of mistakes, difficulties and assistance
needed at each step of the testing procedure from opening the package to reading the
results. Inter-reader concordance for self-test results was defined as agreement between
the results interpreted by the participant and by a study staff member, reported as a per-
centage. Inter-operator concordance was defined as agreement between the results of the
self-testing reported by the participant and results of professional use test conducted by
a study staff member, reported as a percentage. Cohen’s Kappa statistic was calculated
for both inter-reader and inter-operator concordance. When there was only one rating,
Gwet’s AC coefficient was used to assess level of agreement. Acceptability and attitudes
about self-testing were reported as frequencies and described descriptively. We also used
Chi-square test to explore the factors associated with user errors. The statistical analysis
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was performed with software MedCalc version 14.8.1 (MedCalc Software Ltd, Acacialaan,
Ostend, Belgium).
3.6. Ethical Approval
The Review Board in Bio-medical Research at National Institute of Hygiene and
Epidemiology, Hanoi, Vietnam approved the study on 30 July 2019 (IRB-VN01057/IORG
0008555, number NIHE IRB—20/2019).
4. Results
4.1. Patient Recruitment and Characteristics
A total of 327 individuals (182 PWID and 145 MSM) were approached and screened
for eligibility. Among 282 eligible participants (141 PWID and 141 MSM), 270 (95.7%)
agreed to participate in the study (131 PWID and 139 MSM). However, due to the time
delay between agreement and enrollment, only 77.4% (209/270) participants were available
and enrolled in the study (105 PWID and 104 MSM) during the data collection period,
October–December 2019, (Figure 1).
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Figure 1. Flowchart of eligible individuals who were enrolled in the study (PWID: people who inject
drugs and MSM: men who have sex with men).
The baseline characteristics of artici a ts i t e t o ro s are s o i able 1.
Co pare t t r , I ere ore likely to be older (median age: 45 vs.
22 years; p < 0. 001), less educated (coll ge, the highest l vel obtained in both groups: 1%
in PWID vs. 87.5% in MSM, p < 0.0 01) and r l . i P I vs. 2.9% in
MSM; p < 0.0001). S ere also ore likely to be a are of self-testing than P ID (87.5%
vs. 32.4%; p < 0.0 1). A ong two cohorts, only one participant in PWID had experience
with self-testing, which was related to monitoring glucose as part of diabetes anage ent.
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Table 1. Baseline demographic characteristics of study participants.
Demographic Characteristics PWID (n = 105) MSM (n = 104) p Value
Age, years, median (range) 45 (31–62) 22 (18–26) <0.0001
Sex, % (n)
Male 98.1 (103) 100.0 (104) 0.497
Female 1.9 (2) 0
Education, % (n) <0.0001
Primary school 6.7 (7) 0
Secondary school 55.2 (58) 0
High school 37.1 (39) 12.5 (13)
College 1.0 (1) 87.5 (91)
Occupation, % (n) <0.0001
Unemployed 48.6 (51) 2.9 (3)
Employed 51.4 (54) 97.1 (101)
Marital status, % (n) <0.0001
Married or living with a partner 57.1 (60) 2.9 (3)
Divorced, separated or widow 17.1 (18) 1.0 (1)
Unmarried 25.7 (27) 96.2 (100)
Self-reported exposures (ever) to any following risk factors
for HCV infection, % (n)
Injecting non-prescribed drugs 100.0 (105) 0 <0.0001
Sharing needles 46.7 (49) 0 <0.0001
Condomless anal intercourse 6.7 (7) 100 (104) <0.0001
A surgical procedure 11.4 (12) 15.4 (16) 0.424
A dental procedure 27.6 (29) 45.2 (47) 0.009
Sharing shaving tools or toothbrushes 25.7 (27) 28.8 (30) 0.643
Having a tattoo 32.4 (34) 6.7 (7) <0.0001
Aware of the existence of self-tests performed at home, % (n) 32.4 (34) 87.5 (91) <0.0001
Previous use of self-test, % (n) 1.0 (1) 0 1.000
4.2. Usability of Self-Testing Performed by Participants
HCVST procedures included completing 12 steps starting with opening the pouch
and ending with interpreting the test result. Table 2 reports observer assessment of user
mistakes completing steps overall and Table 3 reports observed difficulties and required
assistance while self-testing.




n % n %
Pretesting
1. Opening the pouch and taking all contents out 0 0 0 0
2. Reading/using the instructions for use 2 1.9 0 0 0.498
3. Removing the test tube from the pack 0 0 0 0
4. Removing the cap from the test tube 2 1.9 0 0 0.498
5. Sliding the test tube into the stand 1 1 1 1 1.000
6. Pouring the fluid from the test tube into the stand 4 3.8 1 1 0.369
7. Removing the test device from the pack 0 0 0 0
Conduct of Test
8. Touching the test pad 7 6.7 4 3.8 0.538
9. Incorrectly collecting oral fluid sample * 39 37.1 14 13.5 0.0001
10. Wrong placing the test device in the test tube 3 2.9 1 1 0.621
11. Test device coming out of the tube while testing 0 0 0 0
12. Not reading the result between 20 and 40 min 4 3.8 2 1.9 0.683
Test Interpretation
13. Wrong interpreting the test result ** 21 20 1 1 <0.0001
* Correct manipulation is indicated in the instruction guide provided for participants: “Firmly put the flat pad to the gums and swab along
the upper outer gum one time and along lower outer gum onetime”; ** Step considered correct if results read by the study participant agree
with rereading by a trained staff.
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Table 3. Observer assessment of difficulties and steps requiring assistance.
Testing Step, % (n)





n = 105 n = 104 n = 105 n = 104
Opening the pouch and taking all the contents out 6.7 (7) 4.8 (5) 0.768 15.2 (16) 2.9 (3) 0.003
Reading/using the instructions for use NA NA 16.2 (17) 0 (0) <0.0001
Removing the cap from the test tube 21.0 (22) 19.2 (20) 0.863 21.9 (23) 1 (1) <0.0001
Sliding the test tube into the stand 11.4 (12) 1.9 (2) 0.01 17.1 (18) 0 (0)
Collecting the oral fluid sample NA NA 21.9 (23) 0 (0) <0.0001
Placing the test device in the test tube 1.0 (1) 1.9 (2) 0.621 15.2 (16) 1.9 (2) 0.0008
Interpreting the test result 13.3 (14) 1.9 (2) 0.003 26.7 (28) 2.9 (3) <0.0001
* Three participants had previous problems with their hand/s (injury and disability) and eight participants had poor eyesight that prompted
request for assistance from study staff.
Both groups were generally able to self-test without errors. PWID were more likely
to incorrectly interpret their HCVST result compared to MSM (20% vs. 1%; p < 0.0001)
(Table 2). The most common mistake observed was incorrect collection of the oral fluid
specimen (37.1% in PWID and 13.5% in MSM; p = 0.0001). The second most common
mistake was touching the flat pad (used for collecting oral fluid) (6.7% in PWID and 3.8%
in MSM; p = 0.538).
For those needing assistance, the most difficult step was removing the cap from
the developer solution (PWID: 21% of PWID and MSM: 19.2%) (Table 3). Sliding the
developer solution into the stand was more challenging for PWID than MSM (11.4% vs.
1.9%; p = 0.010). PWID needing assistance also had more difficulty interpreting their result
correctly than did MSM (13.3% vs. 1.9%; p = 0.003).
PWID also required more assistance, at all steps, than MSM (Tables 2 and 3). Among
all participants with at least one mistake observed, PWID with and without study staff
assistance made significantly more errors than MSM with or without study staff assistance.
Any observed mistake, difficulty and provided assistance in the PWID group (62.9%
[66/105], 53.3% [56/105] and 66.7% [70/105], respectively) were significantly higher than
in the MSM group (33.7% [35/104], 28.8% [30/104] and 17.3% [18/104], respectively). The
difference in proportions of any mistake, difficulty, and assistance between the two groups
were statistically significant.
We also analyzed the association between demographic characteristics and levels of
usability (mistakes, difficulties or provision of assistance). We found older age (>45 years),
lower educational level (primary or intermediate school), and marital status (married) were
associated with higher proportion making either a mistake, having trouble or requiring
assistance (Table 4).
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Table 4. Association between personal factors and usability of the hepatitis C virus (HCV) self-test.
Demographic Characteristics
Mistake Difficulty Assistance
n % p n % p n % p
Age, years, median (range)





<0.000122–45 (N = 107) 44 41.1 40 37.4 41 38.3
>45 (N = 51) 36 70.6 31 60.8 38 74.5
Sex, % (n)
Male (N = 207) 48.8 101 41.1 85 42.0 87
Female (N = 2) 0.0 0 50.0 1 50.0 1
Educational level, % (n)






Intermediate school (N = 58) 41 70.7 33 56.9 43 74.1
Secondary school (N = 62) 27 43.5 23 37.1 22 35.5
College (N = 92) 29 31.5 25 27.2 17 18.5
Occupation, % (n)





0.0651Employed (N = 155) 69 44.5 61 39.4 59 38.1
Marital status, % (n)





<0.0001Divorced, separated or widow (N = 19) 7 36.8 6 31.6 12 63.2
Unmarried (N = 127) 48 37.8 42 33.1 37 29.1
4.3. HCV Testing Results
The HCV testing results performed by the participants (self-testing), re-interpreted by
the study staff (rereading), and performed by study staff (retesting) in PWID and MSM are
summarized in Figure 2. The self-testing results of the PWID group were 61.0% positive,
28.6% negative, 3.8% invalid, and 6.6% unable to interpret. Compared to the reference
result determined with retesting performed by study staff, the positive rate with self-testing
was lower in PWID group (61% vs. 77.1%; p = 0.01). In MSM group, 99% participants
interpreted their results as negative and 1% as invalid while on rereading by study staff,
one was read as a positive result. However, on retesting, the result was confirmed negative.
Table 5 shows the concordance of results between those interpreted by participants
and study staff in both groups. In the PWID group, the Cohen’s Kappa coefficient for
inter-reader agreement was 0.77. The concordance of inter-reader results in this group was
88.6% (93/105). There were five cases in which the participants interpreted the results as
negative, but the results were all positive when reread by study staff. In another seven
cases, where the participants were not able to interpret their results, the study staff reread
and found four cases had positive results and three cases had invalid results. For inter-
operator agreement in PWID, the Cohen’s Kappa coefficient was 0.61. The concordance of
results between “self-testing” and “retesting” was 81.9% (86/105). There were eight cases
in which the participants interpreted the results as negative, but they were all positive
when the study staff retested. In the other four cases, which the participants interpreted as
invalid results, two cases were positive and two were negative on retesting. There were
seven cases in which the participants were not able to interpret their results, and all the
results were positive when the seven participants were retested by staff.
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in which the participants interpreted the results as negative, but they were all positive 
when the study staff retested. In the other four cases, which the participants interpreted 
as invalid results, two cases were positive and two were negative on retesting. There were 
Figure 2. Summary of HCV testing results in PWID (A) and MSM (B) for participant self-testing, rereading by trained staff,
and retesting performed by trained staff.
Table 5. The concor ance of HCV testing results performed by the participants (self-testing), re-interpreted by the health
care staff (rereading) and performed by the study staff (retesting) in PWID and MSM.
PWID (n)
Rereading by Trained Staff
(Inter-Reader)
Retesting by Trained Staff
(Inter-Operator)






ng Positive 64 0 0 0 64 0 0 0
Negative 5 25 0 0 8 22 0 0
Invalid 0 0 4 0 2 2 0 0
Unsure 4 0 3 0 7 0 0 0
Concordance (%) Between self- sting and rereading: 88.6% B tween self-te ti g and retesting: 81.9%
Cohen’s Kappa 0.77 0.61
MSM (n)
Rereading by Trained Staff
(Inter-Reader)
Retesting by Trained Staff
(Inter-Operator)






ng Positive 0 0 0 0 0 0 0 0
Negative 1 102 0 0 0 103 0 0
Invalid 0 0 1 0 0 1 0 0
Unsure 0 0 0 0 0 0 0 0
Concordance (%) Between self-testing and rereading: 99% Between self-testing and retesting: 99%
Cohen’s Kappa 0.66 0.99 *
* Gwet’s AC coefficient.
In the MSM group, the Cohen’s Kappa coefficient for inter-reader agreement was 0.66.
The concordance of results between “self-testing” and “rereading” was 99% (103/104).
There was one case, in which the participant identified the result as negative, but it was
determined as weak positive by a study staff member on rereading. For the inter-operator
agreement, the Gwet’s AC coefficient was 0.99. The concordance of results between “self-
testing” and “retesting” was 99% (103/104). There was one case in which the participant
identified the result as invalid, but it was negative upon retesting by a study staff member.
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A total of 21 participants among 105 PWID (20%) and one participant among 104 MSM
(1%) received discordant results between self-testing, rereading and retesting. All the
discordant results from the 22 participants are listed in Table 6 and classified in four
groups. The first group included six participants who incorrectly interpreted their results.
All the results of these six participants were read by study staff as positive or weak
positive, while after retesting the results of two participants changed from weak positive to
negative. Among these six participants, one had poor eyesight, one did not understand
the instruction, and two made mistakes during sample collection. The second group
included four participants who correctly interpreted their result, but the self-test results
were inconsistent with the retesting results performed by study staff. We observed that
two of the four participants had incorrect sample collection. Five participants in the third
group interpreted their results as invalid which were consistent with rereading by study
staff; however, after retesting, three had negative results and all three of these had issues
with sample collection. The other two had positive results after retesting but no mistake
was observed. The fourth group listed seven participants who were unable to interpret
their results even after assistance was provided to four out of seven participants. Four of
the tests were read as positive by the study staff and all seven were positive after retesting.
Among these seven participants, four had poor eyesight and one made mistakes while
collecting the sample.
Table 6. Discordant results among self-testing, rereading (interpreted by study staff) and retesting (by the study staff) in
PWID and MSM groups.









Wrong Result Interpretation by Participants (n = 6)




PWID-022 Negative Positive Positive No Correct No
PWID-048 Negative Weak Positive Positive No Correct Yes Participant had pooreyesight
PWID-082 Negative Positive Positive No Incorrect Yes
Participant placed
device on the tongue
and swabbed the teeth
PWID-097 Negative Weak positive Negative No Incorrect No Participant placeddevice on the tongue
MSM-062 Negative Weak Positive Negative No Correct Yes
Correct Result Interpretation by Participant but Retesting Result Differing from Self-Testing Result (n = 4)
PWID-073 Negative Negative Positive No Correct No
PWID-075 Negative Negative Positive No Incorrect No Participant swabbedthe teeth
PWID-105 Negative Negative Weak positive No Correct No
PWID-106 Negative Negative Positive No Incorrect No Participant swabbedtongue and teeth
Correct Interpretation of Invalid Results in Self-Testing (n = 5)
PWID-010 Invalid Invalid Positive No Correct No
PWID-077 Invalid Invalid Positive No Correct No
PWID-017 Invalid Invalid Negative No Incorrect No Participant swabbedon one gum only
PWID-054 Invalid Invalid Negative No Incorrect No Participant did not usethe whole pad
MSM-066 Invalid Invalid Negative Yes Incorrect No Participant did notswab firmly enough
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Table 6. Cont.









Unsure How to Interpret the Results in Self-Testing (n = 7)
PWID-036 Unsure Positive Positive No Correct Yes Participant had pooreyesight
PWID-052 Unsure Positive Positive No Correct Yes Participant had pooreyesight
PWID-053 Unsure Positive Positive No Correct Yes
PWID-092 Unsure Positive Positive No Incorrect No Participant did not usethe whole pad
PWID-043 Unsure Invalid Positive No Correct Yes
PWID-059 Unsure Invalid Positive No Correct No Participant had pooreyesight
PWID-064 Unsure Invalid Positive No Correct No
4.4. Acceptability and User Perspectives on HCVST
After self-testing, participants provided their perspectives regarding perceptions of
HCV self-test difficulty level at different steps (Figure 3).




Figure 3. Participants’ perceptions of HCV self-test usability at different steps. 
Table 7 summarizes all the study outcomes. Acceptability was evaluated before and 
after self-testing. High acceptability in both groups was recorded (>90%). The majority of 
the participants indicated a preference to test by themselves at home for HCV infection in 
the future (69.5% in PWID and 76.9% in MSM, p = 0.275) and their preferred sample type 
was oral fluid. Usability in MSM was significantly better than that in PWID, along with 
higher concordance of results in MSM compared to PWID. 
Table 7. Summary of acceptability, preference, usability and concordance results of HCV self-testing (HCVST). 
% (n) PWID MSM p Value 
Acceptability, % (n) n = 105 n = 104  
Before self-testing    
The proportion of participants among eligible subjects who 
agreed to participate and perform HCV self-testing 
92.9 (131/141) 98.6 (139/141) 0.034 
Ready to use HCV self-test if available 98.1 (103) 100.0 (104) 0.498 
After self-testing    
Willing to use HCV test again 91.4 (96) 98.1 (102) 0.058 
Willing to recommend the test to family and friends 99 (104) 97.1 (101) 0.369 
Taking the tests to family member/friend 99.0 (104) 97.1 (101) 0.503 
Preferences on HCVST, % (n) n = 105 n = 104  
Preferred approach to test for HCV in the future    
 By myself at home 69.5 (73) 76.9 (80) 0.275 
 By myself at a health center 7.6 (8) 10.6 (11) 0.481 
 In a community center by a healthcare worker 8.6 (9) 5.8 (6) 0.593 
 In a screening campaign 0 (0) 2.9 (3) 0.121 
Preferred sample type    
 Prefer oral fluid-based test 79 (83) 67.3 (70) 
0.416  Prefer blood-based test 10.5 (11) 26.9 (28) 
 No preference 10.5 (11) 5.8 (6) 
Steps to take if results of self-test reactive    
 Contact healthcare facility 95.2 (100) 83.7 (87) 0.006 
 Contact pharmacy 1.9 (2) 1.9 (2) 1.000 
Figure 3. Participants’ perceptions of self-test usability at different steps.
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Table 7. Summary of acceptability, preference, usability and concordance results of HCV self-testing (HCVST).
% (n) PWID MSM p Value
Acceptability, % (n) n = 105 n = 104
Before self-testing
The proportion of participants among eligible
subjects who agreed to participate and
perform HCV self-testing
92.9 (131/141) 98.6 (139/141) 0.034
Ready to use HCV self-test if available 98.1 (103) 100.0 (104) 0.498
After self-testing
Willing to use HCV test again 91.4 (96) 98.1 (102) 0.058
Willing to recommend the test to family and
friends 99 (104) 97.1 (101) 0.369
Taking the tests to family member/friend 99.0 (104) 97.1 (101) 0.503
Preferences on HCVST, % (n) n = 105 n = 104
Preferred approach to test for HCV in the future
By myself at home 69.5 (73) 76.9 (80) 0.275
By myself at a health center 7.6 (8) 10.6 (11) 0.481
In a community center by a healthcare worker 8.6 (9) 5.8 (6) 0.593
In a screening campaign 0 (0) 2.9 (3) 0.121
Preferred sample type
Prefer oral fluid-based test 79 (83) 67.3 (70)
0.416Prefer blood-based test 10.5 (11) 26.9 (28)
No preference 10.5 (11) 5.8 (6)
Steps to take if results of self-test reactive
Contact healthcare facility 95.2 (100) 83.7 (87) 0.006
Contact pharmacy 1.9 (2) 1.9 (2) 1.000
Do a confirmatory test 28.6 (30) 57.7 (60) <0.0001
Seek advice from a family
member/community 13.3 (14) 11.5 (12) 0.831
Do not know 1.0 (1) 0 (0) 1.000
Knowledge about HCV treatment
Know that HCV can be cured 64.8 (68) 55.8 (58) 0.205
Know that there is a treatment but not sure
about the cure 10.5 (11) 19.2 (20) 0.083
Not sure if there is treatment 4.8 (5) 8.7 (9) 0.284
There is no treatment or cure 0 (0) 1.9 (2) 0.246
Usability, % (n)
Correctly completing self-testing without any
mistake 37.1 (39) 66.3 (69) <0.0001
Correctly collecting oral fluid 62.9 (66) 86.5 (90) 0.0001
Correctly interpreting the self-test results 80 (84) 99 (103) <0.0001
Completing self-test procedure without
difficulty 46.7 (49) 71.2 (74) 0.0004
Completing self-test procedure without
assistance 33.3 (35) 82.7 (86) <0.0001
Concordance of Results
Inter-reader agreement
Concordance, % (n) 88.6% (93) 99% (103) 0.005
Kappa value 0.77 0.66
Inter-operator agreement
Concordance, % (n) 81.9% (86) 99% (103) <0.0001
Kappa value 0.61 0.99
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5. Discussion
5.1. Summary of Findings
To our knowledge, this is one of the first studies to examine the acceptability and
usability of HCVST in high-risk populations in a non-clinical setting. The study was
conducted with PWID and MSM groups in a province of northern Vietnam. PWID were
significantly older (median: 45 vs. 22 years) and had a lower educational level compared
to MSM (Table 1).
5.1.1. Usability
The MSM group showed a significantly greater ability to correctly complete the self-
testing procedure (66.3% vs. 37.1%, p < 0.0001), to complete HCVST without difficulty
(71.2% vs. 46.7%, p = 0.0004) and without assistance (82.7% vs. 33.3%, p < 0.0001) compared
to PWID (Table 7). In the PWID group, the collection of oral fluid samples and result
interpretation were the two steps at which mistakes were most commonly observed (37.1%
and 20%, respectively) (Table 2). These two steps were also the ones most commonly
requiring assistance (21.9% and 26.7%). This was attributed to specific factors in these
participants, including older age, lower educational background and health factors (poor
eyesight, injuries to the hand, or mental condition). The difference in the proportion of
participants observed to correctly complete steps, interpret results, and required assistance
self-testing indicated that PWID may need more support self-testing, at least in the early
days of implementation. Other HIVST studies have also reported that a common mistake in
HIV self-testing was sample collection, and older individuals and those with lower levels
of education were more prone to make errors. In a systematic review of reliability of the
HIV rapid diagnostic test for self-testing [16], it was reported that the most common error
that affected test performance was incorrect specimen collection. In another systematic
review on acceptability of HIV self-testing, it was reported that accurate performance
was associated with the level of education, and misinterpretation of photo results was
associated with older age, although generally rare (4.9%) [15].
5.1.2. Concordance of Results
Overall, there was good agreement between inter-reader and inter-operator in both
groups. The concordance in the MSM group for both inter-reading and inter-operator (99%)
was higher than that in the PWID group (88.6% and 81.9%). With the inter-reading measure,
the Cohen’s Kappa coefficient in the PWID group (0.77) was relatively higher than that in
MSM group (0.66). For inter-operator measure, the Cohen’s Kappa coefficient in PWID
(0.61) was lower than that in MSM group (0.99). The common mistakes we observed that
affected the self-test results were incorrect sample collection, errors due to poor eyesight or
difficulty in understanding the instruction. Assistance may be needed for those who have
issues with reading or understanding the instructions. A demonstration video would be
helpful in these cases. In 2019, Kimble et al. evaluated the performance of the OraQuick
HCV Rapid Antibody Test in oral fluid when used by 95 patients (48 males and 47 female)
for self-testing in the United States [21]. The authors reported that the test kit showed good
performance when used by patients: sensitivity and specificity on self-collected oral fluid
samples were 88.4%% (95% CI, 74.9–96.1) and 100% (95% CI, 93–100), respectively, when
patients interpreted the test results. Sensitivity and specificity were 97.7% (95% CI, 88–99.9)
and 98% (95% CI, 89.6–100), respectively, when trained staff interpreted the result. The
Cohen’s Kappa coefficient was reported as 0.89 for inter-reading in this study.
5.1.3. Acceptability
There was high acceptability of HCV self-testing with more than 90% agreeing to
participate in the study (92.9% of PWID and 98.6% of MSM). After the self-testing experi-
ence, the participants expressed a willingness to use an HCV self-test again or to introduce
the self-test to family members and friends (Table 7). In 2018, in the first study to report
on the acceptability of HCV self-testing performed by un-trained users [22], Guise et al.
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conducted qualitative rapid assessment to explore acceptability and key challenges of HCV
self-testing among 22 study participants across three focus groups of PWID in the UK. The
study showed potential acceptability but also revealed multiple concerns associated with
self-testing such as poor access to confirmatory testing and care.
5.2. The Performance and Applicability of OraQuick HCV Antibody Self-Test
The clinical performance of the OraQuick HCV test has been evaluated and shown to
be comparable to that of laboratory-based tests with both serum and oral fluid [23]. Overall,
eight studies reported sensitivity and specificity of OraQuick (OraSure Technologies, PA,
USA) with a total sample of 9024. The sample size of these studies ranged from 172
to 2183, sensitivities from 90% to 100%, and specificities from 95% to 100% [23]. The
pooled sensitivity and specificity were 98% (95% CI: 97%–99%) and 100% (95% CI: 90%–
100%), respectively. Among studies that assessed individual oral RDTs, the eight studies
showed that OraQuick ADVANCE® had a slightly higher sensitivity (98%, 95% CI: 97–
98%) compared to the other oral brands (pooled sensitivity: 88%, 95% CI: 84–92%). The
performance characteristics of OraQuick had previously met the quality standards of
RDT testing for oral specimen; therefore, in our study, we did not include testing using a
reference assay to determine the sensitivity and specificity of the self-testing performed
by the un-trained users. We focused mainly on the issues of acceptability and usability of
HCV self-testing in two key populations, as these issues are critical in terms of feasibility
and scale-up, and to improve the product to be more user-friendly.
Our findings have important implications for further work on self-testing. First,
the higher proportion of PWID who experienced difficulties correctly performing the
test, interpreting the results independently suggests that some individuals may require
assistance, and face-to-face guidance or video demonstration would be useful. Second, we
observed several steps where there were consistent difficulties, and we propose specific
modifications to the product to improve the usability. The tube containing reagent was
designed with a flip top cap, but participants often mistook them for screw cap tubes, which
resulted in difficulty in opening the tube. The font size of the written instructions and the
photo of result illustration were not large enough for those individuals with poor eyesight.
The workflow of the testing procedure could be displayed in vertical order from the upper
side down to the lower side in the instruction paper frame to prevent misunderstandings
about the correct sequence of steps.
Other issues that need to be addressed are strategies to ensure prompt linkage and
access to HCV viral load testing to confirm chronic HCV infection and need for treatment.
At present, this represents a major barrier in access to care and treatment, especially among
marginalized populations. There are also concerns that self-testing while promoting access
to serological testing may result in sub-optimal linkage and uptake of treatment.
The implementation of HCV self-testing in Vietnam is important because key popula-
tions account for a significant proportion of the almost one million HCV-infected persons
in the country. Based on 2013 estimates, there are around 271,506 PWID, 382,506 MSM and
71,936 sex workers in Vietnam, and all of them should be offered and have regular access
to testing for HIV, hepatitis C and B, and sexually transmitted infections [24]. Self-testing
represents a potential option to expand this access. Additionally, Vietnam has good experi-
ence in implementing HIV self-testing. The national guidelines for community-based HIV
testing including HIV self-testing were approved by the Vietnam Ministry of Health in
2018 after one year of piloting in selected provinces [25]. HIV self-testing has now been
scaled up country wide. The feasibility and effectiveness of HIV self-testing in case finding
and linkages to care has been reported [20]. This represents a strong foundation for the
implementation of HCV self-testing once test kits are made available for communities.
This study presented some limitations. The convenience sampling may present a
selection bias in PWID and MSM at the selected local sites. Given the low positive rate of
anti-HCV in the MSM group, a larger sample size for MSM would be better to assess the
concordance of the test results. Also, female sex workers as one of the key populations was
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not included in this study. Finally, assessment for dual risk and screening for high risk for
HCV acute infection were not conducted in this study.
6. Conclusions
This study shows a favorable experience with an oral fluid HCV self-test in two key
populations, PWID and MSM. Self-testing for HCV may also be a good option for other
populations to learn their HCV status. Additional assistance such as demonstration videos
or support from health staff or peer educators during the self-testing process may be
needed for individuals who conduct self-testing for the first time or who have difficulty
in following instructions for users. The study findings provide important information
for development of HCVST that may facilitate scale-up of HCV screening and improve
coverage of HCV treatment. This emerging evidence provides a strong foundation to
support further studies to inform global, regional, and national HCV testing policy and
expanded access to HCV testing.
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